BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Head-to-Head Data on AstraZeneca PLC (AZN)'s Crestor Vs. Pfizer Inc. (PFE)'s Lipitor Results Due Soon


8/31/2011 8:06:49 AM

Headline results from an important clinical trial comparing AstraZeneca's cholesterol fighter Crestor to Pfizer's Lipitor could be released imminently, according to an analyst note on Wednesday. An AstraZeneca spokesman confirmed to Reuters the trial was complete, with the last patient visit having taken place. The company is targeting a presentation of the full results at the annual meeting of the American Heart Association in November. That timetable means it is possible AstraZeneca will also pre-announce "top-line" results for the study in the coming weeks, since drugmakers often give a short summary of clinical trials when the results are deemed to be material.

Read at Reuters

Reuters
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES